NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Rakuten Medical

Rakuten Medical

Private
San Diego, CaliforniaHealthcare & Life Scienceshttps://rakuten-med.com/us/

Last Round

Series F

Jan 7, 2026

Est. Valuation

$1.2B

Total Funding Raised

$1.19B

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Rakuten Medical is a biotechnology company that develops precision-targeted cancer therapies aimed at treating solid tumors through the use of monoclonal antibody conjugates activated by light to selectively eliminate cancer cells while preserving healthy tissue.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Precision Medicine, Medical Devices, Clinical Trials, Drug Discovery

Business Model

B2B

Customer Profile

Hardware Sales, Services & Consulting

AI Layer

Non-AI

Keywords

photoimmunotherapyPITcancer therapyprecision oncologydrug-device combinationlight-activated therapytargeted cancer treatmentbiotechnologymedical laserantibody-dye conjugatehead and neck canceroncology pipelineclinical stage biotechcancer techmedtech

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Rakuten Medical Comparables

Compare Rakuten Medical with similar companies based on industry and business-model similarity.

Rakuten Medical comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
ImPact Biotech
78%
Aura Biosciences
73%
Hemerion Therapeutics
69%

Rakuten Medical Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series FJan 7, 2026
Series EMar 6, 2024
Convertible DebtDec 1, 2022
Series DJul 28, 2021
Series C ExtensionJul 31, 2019
Series C
Dec 20, 2018

Key People

Founding team and executive leadership

Hiroyuki Kodama

Chief Product Officer, Representative Director, President, Rakuten Medical K.K.

Executive Team

Andrew Liu

Chief Financial Officer

Executive Team

Rakuten Medical Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 21, 2026

    New preclinical findings presented at AACR 2026 on photoimmunotherapy platform.

  • Apr 21, 2026

    Presented new preclinical findings at the AACR 2026 conference.

Rakuten Medical Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Rakuten Medical Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Rakuten Medical's valuation, stock price, and market status.

Firmographic Details

HeadquartersSan Diego, California
Employee Range129
Year Founded2010
Last FundingJan 7, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.